Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria | MicrobiomeTrials
Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-07Est. Completion: 2027-07
Enrollment target: 48 participants
Locations
The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
Beijing Tsinghua Changgung Hospital, Beijing, Beijing Municipality, China
The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing Municipality, China
Foshan Nanhai District People's Hospital, Foshan, Guangdong, China
The First Clinical College of Guangzhou Medical University, Guangzhou, Guangdong, China
Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, China
The Second Hospital Of Hebei Medical University, Shijiazhuang, Hebei, China
Henan Provincial People's Hospital, Zhengzhou, Henan, China
Zhengzhou Central Hospital, Zhengzhou, Henan, China
The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
Xiangya Hospital of Central South University, Changsha, Hunan, China
People's Hospital of Hunan Province, Changsha, Hunan, China
The Third Hospital of Changsha, Changsha, Hunan, China
Other microbiome trials you might be interested in